“Pincer Attack” on Transcription Factors Offers New Possibilities for Future Blood Cancer Therapies
Research at Karl Landsteiner University of Health Sciences demonstrates synergistic effect of inhibiting two regulatory proteins in multiple myeloma. Krems (Austria), 16. October 2024: The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood cancer. […]